ZTS · 10-Q · 2026Q2 · Full report

Competition and Pricing Pressure

Zoetis Inc. · 2026-08-06 · Importance 60 · Surprise 40

U.S. companion animal revenue declined 11% in both the three- and six-month periods ended June 30, 2026, primarily because of softer end-market demand and an increasingly competitive landscape. The key dermatology franchise and Simparica Trio faced heightened competitive pressure and persistent macroeconomic-driven price sensitivity. Generic competition reduced sales of Cerenia and Convenia, while Librela sales also declined. International companion animal growth was partly offset by decreased sales of key dermatology products.

Key facts

• Companion animal revenue decline in the U.S. was primarily due to softer end-market demand and heightened competitive pressure on the key dermatology franchise and Simparica Trio, impact of generic competition on Cerenia and Convenia, and lower sales of Librela. source